Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001214686 | SCV001386381 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-05-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala823Valfs*23) in the RPGRIP1L gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1L are known to be pathogenic (PMID: 17558409). This variant is present in population databases (rs771129715, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with RPGRIP1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 944314). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005012620 | SCV005642051 | likely pathogenic | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2024-06-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004733180 | SCV005359371 | likely pathogenic | RPGRIP1L-related disorder | 2024-04-09 | no assertion criteria provided | clinical testing | The RPGRIP1L c.2468_2477del10 variant is predicted to result in a frameshift and premature protein termination (p.Ala823Valfs*23). This variant has been reported in study assessing carrier frequency of autosomal recessive variants in inherited retinal disease (Hanany et al. 2020. PubMed ID: 31964843). This variant is reported in 0.0026% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in RPGRIP1L are expected to be pathogenic. This variant is interpreted as likely pathogenic. |